Wnt signaling pathway in invasive ductal carcinoma of the breast: Relationship between β-catenin, disheveled and cyclin D1 expression

Oncology

Volumn 73, Issue 1-2, 2008, Pages 112-117

  Prasad, Chandra P ^a   Gupta, Siddhartha D ^a   Rath, Gayatri ^b   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Cyclin D1; Disheveled; Invasive ductal carcinoma; Wnt catenin pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; DISHEVELLED PROTEIN; TUMOR MARKER; WNT PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION; WNT PROTEINS;

EID: 41549152176     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000120999     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;8:S4-S66.
3. Report of the National Cancer Registry Programme. New Delhi, Indian Council of Medical Research, 2001, p 22.
4. Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K, Mandinova A, Raffoul W, Fiche M, Dotto GP, Brisken C: Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci USA 2006;103:3799-3804.
5. Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD: Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis 2006;27:1341-1348.
6. Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O, Durst M, Kristiansen G, Huszka C, Knuchel R, Dahl E: Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 2006;25:3479-3488.
7. Benhaj K, Akcali KC, Ozturk M: Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 2006;15:701-707.
8. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A: The cyclin D1 gene is a target of the betacatenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
9. Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J: Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2003;106:208-215.
10. Ozaki S, Ikeda S, Ishizaki Y, Kurihara T, Tokumoto N, Iseki M, Arihiro K, Kataoka T, Okajima M, Asahara T: Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol Rep 2005;4:1437-1443.
11. Barth AI, Nathke IS, Nelson WJ: Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol 1997;9:683-690.
12. Ilyas M, Tomlinson IP: The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol 1997;182:128-137.
13. Kuroda H, Tamaru J, Takeuchi I, Ohnisi K, Sakamoto G, Adachi A, Kaneko K, Itoyama S: Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast. Virchows Arch 2006;448:500-505.
14. Yang JF, Chen SL, Liu ZH, Zhang Y: Correlation among expression of E-cadherin, betacatenin, and cyclin D1 in breast cancers. Ai Zheng 2004;23:799-802.
15. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-1701.
16. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W: Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3 beta. Science 1998;280:596-599.
17. Itoh K, Krupnik VE, Sokol SY: Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 1998;8:591-594.
18. Hamada F, Tomoyasu Y, Takatsu Y, Nakamura M, Nagai S, Suzuki A, Fujita F, Shibuya H, Toyoshima K, Ueno N, Akiyama T: Negative regulation of Wingless signaling by Daxin, a Drosophila homolog of axin. Science 1999;283:1739-1742.
19. Li L, Yuan H, Weaver CD, Mao J, Farr GH 3rd, Sussman DJ, Jonkers J, Kimelman D, Wu D: Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 1999;18:4233-4240.
20. Salic A, Lee E, Mayer L, Kirschner MW: Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the Wnt pathway in Xenopus egg extracts. Mol Cell 2000;5:523-532.
21. Farr GH 3rd, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D: Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol 2001;148:691-702.
22. Viale G: Histopathology of primary breast cancer. Breast 2003;12:391-396.
23. Shukla S, Mirza S, Sharma G, Parshad R, Gupta SD, Ralhan R: Detection of RASSF1A and RARβ : hypermethylation in serum DNA from breast cancer patients. Epigenetics 2006;1:88-93.
24. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-1817.
25. Nagahata T, Shimada T, Harada A, Nagai H, Onda M, Yokoyama S, Shiba T, Jin E, Kawanami O, Emi M: Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci 2003;94:515-518.
26. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A, Armas A: Beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 1999;155:527-536.
27. Morin PJ: Beta-catenin signaling and cancer. Bioessays 1999;21:1021-1030.
28. Kimelman D, Xu W: Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 2006;25:7482-7491.
29. Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL: Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 2006;66:5487-5494.
30. Nakopoulou L, Mylona E, Papadaki I, Kavantzas N, Giannopoulou I, Markaki S, Keramopoulos A: Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome. Mod Pathol 2006;19:556-563.
31. Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810.
32. Itoh K, Brott BK, Bae GU, Ratcliffe MJ, Sokol SY: Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. J Biol 2005;4:3.
33. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007;7:55.
34. Oishi Y, Nagasaki K, Miyata S, Matsuura M, Nishimura S, Akiyama F, Iwai T, Miki Y: Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer. Hum Genet 2007;52:271-279.
35. Glockner S, Lehmann U, Wilke N, Kleeberger W, Langer F, Kreipe H: Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR. Pathobiology 2000;68:173-179.
36. Oliveira AM, Ross JS, Fletcher JA: Tumor suppressor genes in breast cancer: the gate-keepers and the caretakers. Am J Clin Pathol 2005;124(suppl):S16-S28.
37. Caldon CE, Daly RJ, Sutherland RL, Musgrove EA: Cell cycle control in breast cancer cells. J Cell Biochem 2006;97:261-274.
38. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, et al: AJCC Cancer Staging Manual, ed 6. New York, Springer, 2002, pp 171-180.